KPV 10mg, BPC-157 10mg, TB-500 10mg, GHK-Cu 50mg (KLOW 80mg)

Overview

The KLOW Stack combines four independently studied synthetic peptide compounds — KPV, BPC-157, TB-500 (Thymosin Beta-4), and GHK-Cu — each with a distinct preclinical or clinical research profile. The four compounds share research interest across tissue repair biology, extracellular matrix dynamics, angiogenesis, and inflammatory mediator signaling, representing a range of complementary but mechanistically distinct research areas.

KPV is a tripeptide derived from the C-terminus of alpha-melanocyte-stimulating hormone (α-MSH), studied in preclinical models for its effects on inflammatory mediator pathways. BPC-157 is a gastric-origin pentadecapeptide with an extensive preclinical profile in fibroblast-mediated tissue repair and angiogenesis research. TB-500 is the synthetic analog of Thymosin Beta-4, examined for its role in actin regulation and cellular migration in vascular and tissue biology models. GHK-Cu is a copper-binding tripeptide studied for its effects on collagen synthesis, extracellular matrix remodeling, and fibroblast activity. Detailed research findings for each individual compound are available on their respective product pages.

Chemical Profile

KPV (Lys-Pro-Val)

BPC-157 (Body Protection Compound-157)

TB-500 (Thymosin Beta-4)

GHK-Cu (Copper Peptide GHK)

Research Findings

Combination Research Context

Each compound in the KLOW Stack has been studied for distinct but overlapping preclinical mechanisms relating to tissue biology, inflammatory mediator signaling, and extracellular matrix dynamics. KPV has been examined in preclinical models for its effects on inflammatory mediator pathways, including studies investigating melanocortin receptor signaling and cytokine modulation in experimental inflammation models. BPC-157 has a well-documented preclinical profile in fibroblast-mediated tissue repair and angiogenesis, with research spanning connective tissue, vascular biology, and gastrointestinal models. TB-500 has been studied for its actin-regulatory role in cellular migration and vascular tube formation. GHK-Cu has been examined extensively for its effects on collagen synthesis, extracellular matrix remodeling, fibroblast activity, and gene expression modulation in skin and tissue biology research. Formal combination studies for this specific four-compound formulation are limited; detailed research findings for each individual compound are available on their respective product pages.

Areas of Research

• Inflammatory mediator signaling and cytokine research
• Extracellular matrix remodeling and collagen synthesis studies
• Wound repair and tissue remodeling research
• Angiogenesis and vascular biology research
• Cellular migration and actin dynamics research
• Fibroblast activity and proliferation modeling

Research Use Only: This product is sold exclusively for laboratory and scientific research. It is not approved for human or veterinary use or consumption.

Disclaimer: All products distributed by Resolve Peptides are supplied exclusively for controlled laboratory and scientific research. They are not drugs, supplements, or therapies, and have not been approved by the FDA or any regulatory authority for human or veterinary use. These products are not intended for human or veterinary administration. Regulatory status of research peptides is subject to change; it is the responsibility of the researcher to verify current applicable regulations in their jurisdiction prior to purchase. Any references to biological effects are based solely on experimental and preclinical data.